Premium
The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants
Author(s) -
Walker Helen,
Singer C. R. J.,
Patterson Janet,
Goldstone A. H.,
Prentice H. G.
Publication year - 1986
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1986.tb02942.x
Subject(s) - bone marrow , cyclophosphamide , medicine , total body irradiation , chromosome analysis , bone marrow transplant , karyotype , cytogenetics , minimal residual disease , immunology , bone marrow transplantation , pathology , chemotherapy , biology , chromosome , genetics , gene
S ummary . Bone marrow from 39 patients who received a bone marrow transplant (BMT) from a matched donor of different sex were studied by chromosome analysis for evidence of mixed haemopoietic chimaerism (MC). Recipient metaphases were detected in the bone marrow of 10 patients after BMT. Patients in whom MC was detected within 6 weeks of BMT did not all have a poor outcome. Two of seven are disease‐free survivors at > 470 and > 632 d. All three patients in whom MC was diagnosed more than 6 weeks after BMT subsequently relapsed. Four factors appear to be important in determining the probability of relapse when MC is detected in a patient after BMT: the timing of detection of residual recipient cells; the proportion of these cells in the bone marrow; persistence of these cells in increasing proportions; and the karyotype of the recipient metaphases detected. Cytogenetic assessment may provide the earliest indication of relapse in these patients. In addition, this study provides further evidence that cyclophosphamide and total body irradiation, as used in these patients, may be inadequate conditioning therapy for BMT.